Loading…

P278 Feasibility study of adjuvant fluorouracil/epirubicin/cyclophosphamide (FEC 100) followed by triweekly docetaxel (D) plus trastuzumab (H) in HER2/neu positive early breast cancer

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) 2011, Vol.20, p.S66-S67
Main Authors: Tanaka, M, Anan, K, Umeda, S, Yamaguchi, M, Sasaki, H, Rai, Y, Ohno, S, Toh, U, Tamura, K, Mitsuyama, S
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0960-9776
1532-3080
DOI:10.1016/S0960-9776(11)70220-X